nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—ADRA2C—attention deficit hyperactivity disorder	0.412	0.5	CbGaD
Lurasidone—ADRA2A—attention deficit hyperactivity disorder	0.176	0.213	CbGaD
Lurasidone—DRD2—attention deficit hyperactivity disorder	0.133	0.162	CbGaD
Lurasidone—HTR2A—attention deficit hyperactivity disorder	0.103	0.125	CbGaD
Lurasidone—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00885	0.196	CbGeAlD
Lurasidone—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00552	0.122	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.0047	0.104	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00293	0.0648	CbGeAlD
Lurasidone—Ziprasidone—DRD5—attention deficit hyperactivity disorder	0.00145	0.199	CrCbGaD
Lurasidone—Ziprasidone—ADRA2C—attention deficit hyperactivity disorder	0.00137	0.187	CrCbGaD
Lurasidone—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00115	0.0254	CbGeAlD
Lurasidone—HTR7—forebrain—attention deficit hyperactivity disorder	0.0011	0.0242	CbGeAlD
Lurasidone—DRD2—forebrain—attention deficit hyperactivity disorder	0.00104	0.0229	CbGeAlD
Lurasidone—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00097	0.0214	CbGeAlD
Lurasidone—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000927	0.0205	CbGeAlD
Lurasidone—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000804	0.0178	CbGeAlD
Lurasidone—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000757	0.0167	CbGeAlD
Lurasidone—Ziprasidone—DRD4—attention deficit hyperactivity disorder	0.000744	0.102	CrCbGaD
Lurasidone—HTR7—midbrain—attention deficit hyperactivity disorder	0.000724	0.016	CbGeAlD
Lurasidone—DRD2—midbrain—attention deficit hyperactivity disorder	0.000684	0.0151	CbGeAlD
Lurasidone—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000683	0.0151	CbGeAlD
Lurasidone—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000665	0.0147	CbGeAlD
Lurasidone—Ziprasidone—HTR1B—attention deficit hyperactivity disorder	0.000661	0.0903	CrCbGaD
Lurasidone—Ziprasidone—DRD3—attention deficit hyperactivity disorder	0.000642	0.0876	CrCbGaD
Lurasidone—Ziprasidone—DRD1—attention deficit hyperactivity disorder	0.00063	0.086	CrCbGaD
Lurasidone—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000623	0.0138	CbGeAlD
Lurasidone—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000599	0.0133	CbGeAlD
Lurasidone—HTR7—nervous system—attention deficit hyperactivity disorder	0.000595	0.0132	CbGeAlD
Lurasidone—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000586	0.013	CbGeAlD
Lurasidone—Ziprasidone—ADRA2A—attention deficit hyperactivity disorder	0.000585	0.0799	CrCbGaD
Lurasidone—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000578	0.0128	CbGeAlD
Lurasidone—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000573	0.0127	CbGeAlD
Lurasidone—DRD2—nervous system—attention deficit hyperactivity disorder	0.000562	0.0124	CbGeAlD
Lurasidone—HTR7—cerebellum—attention deficit hyperactivity disorder	0.00056	0.0124	CbGeAlD
Lurasidone—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000547	0.0121	CbGeAlD
Lurasidone—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000542	0.012	CbGeAlD
Lurasidone—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000531	0.0117	CbGeAlD
Lurasidone—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000529	0.0117	CbGeAlD
Lurasidone—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000526	0.0116	CbGeAlD
Lurasidone—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000515	0.0114	CbGeAlD
Lurasidone—HTR1A—brain—attention deficit hyperactivity disorder	0.000476	0.0105	CbGeAlD
Lurasidone—HTR7—brain—attention deficit hyperactivity disorder	0.000455	0.0101	CbGeAlD
Lurasidone—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000451	0.00998	CbGeAlD
Lurasidone—Ziprasidone—SLC6A4—attention deficit hyperactivity disorder	0.000447	0.061	CrCbGaD
Lurasidone—Ziprasidone—DRD2—attention deficit hyperactivity disorder	0.000444	0.0606	CrCbGaD
Lurasidone—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000436	0.00965	CbGeAlD
Lurasidone—DRD2—brain—attention deficit hyperactivity disorder	0.00043	0.00951	CbGeAlD
Lurasidone—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.00042	0.00929	CbGeAlD
Lurasidone—ADRA2C—brain—attention deficit hyperactivity disorder	0.000418	0.00924	CbGeAlD
Lurasidone—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000411	0.00908	CbGeAlD
Lurasidone—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000371	0.0082	CbGeAlD
Lurasidone—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000357	0.0079	CbGeAlD
Lurasidone—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000349	0.00772	CbGeAlD
Lurasidone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000343	0.00759	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—attention deficit hyperactivity disorder	0.000343	0.0469	CrCbGaD
Lurasidone—ADRA2A—brain—attention deficit hyperactivity disorder	0.000333	0.00737	CbGeAlD
Lurasidone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000331	0.00731	CbGeAlD
Lurasidone—HTR2A—brain—attention deficit hyperactivity disorder	0.000284	0.00627	CbGeAlD
Lurasidone—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.64e-05	0.000459	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.64e-05	0.000459	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.64e-05	0.000459	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	5.6e-05	0.000456	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.57e-05	0.000453	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.48e-05	0.000446	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.46e-05	0.000444	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.46e-05	0.000444	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.44e-05	0.000443	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.43e-05	0.000441	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.37e-05	0.000437	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.35e-05	0.000435	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.34e-05	0.000435	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.28e-05	0.00043	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.27e-05	0.000429	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.25e-05	0.000427	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	5.24e-05	0.000426	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.18e-05	0.000422	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.18e-05	0.000421	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.13e-05	0.000417	CbGpPWpGaD
Lurasidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.11e-05	0.000416	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.11e-05	0.000416	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	5.1e-05	0.000415	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.09e-05	0.000415	CbGpPWpGaD
Lurasidone—HTR7—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.08e-05	0.000414	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.08e-05	0.000413	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.07e-05	0.000413	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.06e-05	0.000412	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.03e-05	0.000409	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.99e-05	0.000406	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	4.99e-05	0.000406	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.98e-05	0.000405	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.95e-05	0.000403	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.91e-05	0.0004	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.88e-05	0.000397	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.88e-05	0.000397	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.87e-05	0.000396	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.83e-05	0.000393	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.72e-05	0.000384	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.71e-05	0.000384	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.69e-05	0.000381	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.61e-05	0.000376	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.61e-05	0.000375	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000374	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	4.58e-05	0.000372	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.58e-05	0.000372	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.57e-05	0.000372	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.53e-05	0.000368	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.5e-05	0.000366	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.5e-05	0.000366	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.45e-05	0.000362	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.44e-05	0.000361	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.44e-05	0.000361	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.41e-05	0.000359	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.38e-05	0.000357	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.38e-05	0.000357	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.31e-05	0.000351	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.29e-05	0.000349	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.26e-05	0.000347	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.17e-05	0.000339	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.15e-05	0.000338	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.14e-05	0.000337	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.08e-05	0.000332	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.03e-05	0.000328	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.99e-05	0.000324	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	3.99e-05	0.000324	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.96e-05	0.000322	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.92e-05	0.000319	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.91e-05	0.000318	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.83e-05	0.000312	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.8e-05	0.000309	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.79e-05	0.000308	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.78e-05	0.000308	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.77e-05	0.000306	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.76e-05	0.000306	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.72e-05	0.000303	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.68e-05	0.000299	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.64e-05	0.000296	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000285	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.48e-05	0.000283	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.43e-05	0.000279	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.42e-05	0.000278	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.42e-05	0.000278	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.4e-05	0.000277	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000276	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.39e-05	0.000276	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.39e-05	0.000276	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.38e-05	0.000275	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.34e-05	0.000271	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.33e-05	0.000271	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.33e-05	0.000271	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000271	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.31e-05	0.000269	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.31e-05	0.000269	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.31e-05	0.000269	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.31e-05	0.000269	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000268	CbGpPWpGaD
Lurasidone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.29e-05	0.000267	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.28e-05	0.000267	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.27e-05	0.000266	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.25e-05	0.000265	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.23e-05	0.000263	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.22e-05	0.000262	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.2e-05	0.00026	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.18e-05	0.000259	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.18e-05	0.000259	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.16e-05	0.000257	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.000254	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.11e-05	0.000253	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.08e-05	0.000251	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.08e-05	0.00025	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.07e-05	0.00025	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.07e-05	0.00025	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.07e-05	0.000249	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.03e-05	0.000246	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.02e-05	0.000246	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3e-05	0.000244	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.99e-05	0.000243	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.99e-05	0.000243	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.99e-05	0.000243	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.98e-05	0.000242	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.98e-05	0.000242	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.97e-05	0.000241	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.96e-05	0.000241	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.95e-05	0.00024	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.94e-05	0.000239	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.93e-05	0.000238	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.93e-05	0.000238	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.93e-05	0.000238	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.93e-05	0.000238	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.9e-05	0.000236	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.89e-05	0.000235	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.89e-05	0.000235	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.88e-05	0.000234	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.88e-05	0.000234	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.87e-05	0.000234	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.84e-05	0.000231	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.82e-05	0.00023	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.79e-05	0.000227	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.78e-05	0.000227	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.75e-05	0.000224	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.75e-05	0.000223	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.73e-05	0.000222	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.72e-05	0.000221	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	2.72e-05	0.000221	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.7e-05	0.00022	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.69e-05	0.000219	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.69e-05	0.000219	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.67e-05	0.000218	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	2.67e-05	0.000218	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.66e-05	0.000217	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.66e-05	0.000216	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.66e-05	0.000216	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.65e-05	0.000216	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.63e-05	0.000214	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.62e-05	0.000214	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.62e-05	0.000213	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.61e-05	0.000213	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.59e-05	0.00021	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.58e-05	0.00021	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.57e-05	0.000209	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.53e-05	0.000206	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.5e-05	0.000203	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.49e-05	0.000202	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.45e-05	0.0002	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.42e-05	0.000197	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000196	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.41e-05	0.000196	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.41e-05	0.000196	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.38e-05	0.000194	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.35e-05	0.000191	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.31e-05	0.000188	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.24e-05	0.000182	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.000181	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.21e-05	0.00018	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.21e-05	0.00018	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.19e-05	0.000178	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.17e-05	0.000177	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.17e-05	0.000177	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.15e-05	0.000175	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.08e-05	0.000169	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.07e-05	0.000168	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.03e-05	0.000165	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.02e-05	0.000164	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.02e-05	0.000164	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2e-05	0.000162	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.95e-05	0.000159	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.95e-05	0.000159	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.89e-05	0.000154	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.89e-05	0.000153	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.000153	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000148	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.82e-05	0.000148	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.82e-05	0.000148	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000145	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.77e-05	0.000144	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.77e-05	0.000144	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.77e-05	0.000144	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.76e-05	0.000143	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.74e-05	0.000142	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	1.74e-05	0.000142	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.73e-05	0.000141	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.71e-05	0.000139	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.71e-05	0.000139	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.69e-05	0.000137	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.65e-05	0.000134	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	1.65e-05	0.000134	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000134	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	1.64e-05	0.000133	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.62e-05	0.000132	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.6e-05	0.00013	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.59e-05	0.00013	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.59e-05	0.000129	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.57e-05	0.000128	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.57e-05	0.000128	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000126	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.55e-05	0.000126	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.54e-05	0.000126	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.53e-05	0.000125	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.53e-05	0.000124	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.48e-05	0.00012	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.43e-05	0.000116	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.42e-05	0.000116	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.41e-05	0.000115	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.39e-05	0.000113	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.36e-05	0.000111	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.34e-05	0.000109	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.33e-05	0.000108	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.29e-05	0.000105	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.15e-05	9.37e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.11e-05	9.07e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.01e-05	8.23e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	9.41e-06	7.65e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.41e-06	7.65e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.25e-06	7.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.05e-06	7.37e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.6e-06	7e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.24e-06	6.7e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.52e-06	6.12e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.16e-06	5.83e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	7.06e-06	5.75e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.1e-06	4.97e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.91e-06	4.81e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	5.74e-06	4.67e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.7e-06	4.64e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.66e-06	4.6e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.36e-06	4.36e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.27e-06	4.29e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.8e-06	3.9e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.44e-06	1.99e-05	CbGpPWpGaD
